SCHEMBL2283593

SCHEMBL2283593

COCCCOC(=O)N1CCc2ccc(C(=O)NOC3CCCCO3)cc2C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K5 Q99683 4/20 0.39
TMEM97 Q5BJF2 3/20 0.39
SIGMAR1 Q99720 3/20 0.39
CHRM4 P08173 1/20 0.39
HTR1A P08908 1/20 0.39
CHRM5 P08912 1/20 0.39
ADRA2A P08913 1/20 0.39
ADRA2B P18089 1/20 0.39
HRH2 P25021 1/20 0.39
ADRA1D P25100 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
ADRA1A P35348 1/20 0.39
HRH1 P35367 1/20 0.39
ADRA1B P35368 1/20 0.39
DRD3 P35462 1/20 0.39
HTR2B P41595 1/20 0.39
HTR5A P47898 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
HDAC6 Q9UBN7 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2275604 0.97 HDAC6 (0.42) MAP3K5TMEM97SIGMAR1CHRM4HTR1A
SCHEMBL1026981 0.87 POLB (0.42) MAP3K5HRH3HDAC6KDM4ENAMPT
SCHEMBL2278317 0.84 KDM4E (0.42) MAP3K5HDAC6KDM4ENAMPTNPSR1
SCHEMBL2282394 0.84 TMEM97 (0.57) MAP3K5TMEM97SIGMAR1CHRM4HTR1A
SCHEMBL2278277 0.84 HDAC6 (0.44) HRH3HDAC6NR1H2GSTP1GSTM2
SCHEMBL1081890 0.84 POLB (0.42) HDAC6NAMPT
SCHEMBL1026122 0.83 HDAC6 (0.43) MAP3K5HRH3HDAC6NR1H2NAMPT
SCHEMBL1080735 0.81 SYK (0.44) HDAC6
SCHEMBL1024670 0.81 TMEM97 (0.53) MAP3K5TMEM97SIGMAR1CHRM4HTR1A
SCHEMBL2279957 0.81 NAMPT (0.44) HDAC6KDM4ENAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8575193-B2 N-substituted tetrahydroisoquinoline/isoindoline hydroxamic acid compounds 4SC AG (DE) 2013-11-05 US disclosed
US-20110201643-A1 NOVEL N-SUBSTITUTED TETRAHYDROISOQUINOLINE/ISOINDOLINE HYDROXAMIC ACID COMPOUNDS 4SC AG (DE) 2011-08-18 US disclosed
EP-2100879-A1 Novel N-substituted tetrahydroisoquinoline/isoindoline hydroxamic acid compounds 4SC AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110201643-A1 NOVEL N-SUBSTITUTED TETRAHYDROISOQUINOLINE/ISOINDOLINE HYDROXAMIC ACID COMPOUNDS HDAC1, HDAC3, HDAC4 MAP3K5 3277/4885TMEM97 3168/4885SIGMAR1 1674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.